Exosomes are nano-sized extracellular vesicles excreted by mammalian cells that circulate freely in the bloodstream of living organisms. Exosomes have a lipid bilayer that encloses genetic material used in intracellular communication (e.g. double-stranded DNA, micro-RNAs, and messenger RNA). Recent evidence suggests that dysregulation of this genetic content within exosomes has a major role in tumor progression in the surrounding microenvironment. Motivated by this discovery, we focused here on using exosomal biomarkers as a diagnostic and prognostic tool for cancer. In this review, we discuss recently discovered exosome-derived proteomic and genetic biomarkers used in cancer diagnosis and prognosis. Although several genetic biomarkers have been validated for their diagnostic values, proteomic biomarkers are still being actively pursued. We discuss both commercial technologies and emerging technologies for exosome isolation and analysis. Emerging technologies can be classified into optical and non-optical methods. The working principle of each method is briefly discussed as well as advantages and limitations.
Commercial and emerging technologies for cancer diagnosis and prognosis based on circulating tumor exosomes
N. Ohannesian,Loku Gunawardhana,Ibrahim Misbah,Mohsen Rakhshandehroo,Steven H. Lin,Wei-Chuan Shih
Published 2020 in Journal of Physics: Photonics
ABSTRACT
PUBLICATION RECORD
- Publication year
2020
- Venue
Journal of Physics: Photonics
- Publication date
2020-06-10
- Fields of study
Medicine, Physics, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-91 of 91 references · Page 1 of 1
CITED BY
Showing 1-15 of 15 citing papers · Page 1 of 1